XML 52 R90.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidating Financial Information (Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities $ 195,349 $ 209,808
Cash flows from investing activities:    
Sale of investment securities 16,186 14,895
Maturities of investment securities 45,798 16,899
Purchase of investment securities (76,094) (22,516)
Purchase of long-term investments (1,000) 0
Investments in real estate ventures (36,269) (6,132)
Purchase of subsidiaries (323) (370)
Distributions from investments in real estate ventures 30,934 37,819
Increase in cash surrender value of life insurance policies (773) (806)
Decrease in restricted assets 661 254
Investments in subsidiaries 0 0
Proceeds from sale of fixed assets 17 0
Capital expenditures (10,158) (12,546)
Repayments of notes receivable 0 67
Pay downs of investment securities 828 1,293
Investments in real estate, net (1,910) (1,495)
Net cash (used in) provided by investing activities (32,103) 27,362
Cash flows from financing activities:    
Deferred financing costs (36) 0
Repayments of debt (230,874) (1,490)
Borrowings under revolver 204,506 261,058
Repayments on revolver (221,373) (264,654)
Capital contributions received 0 0
Intercompany dividends paid 0 0
Dividends and distributions on common stock (179,449) (169,571)
Distributions to non-controlling interest (285) (2,521)
Proceeds from issuance of Vector common stock 0  
Proceeds from exercise of Vector options 0  
Tax benefit of options exercised 0  
Other (46) 0
Net cash used in financing activities (427,557) (177,178)
Net (decrease) increase in cash, cash equivalents and restricted cash (264,311) 59,992
Cash, cash equivalents and restricted cash, beginning of period 591,729 310,937
Cash, cash equivalents and restricted cash, end of period 327,418 370,929
Consolidating Adjustments    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities (195,005) (174,152)
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Purchase of long-term investments 0  
Investments in real estate ventures 0 0
Purchase of subsidiaries 0 0
Distributions from investments in real estate ventures 0 0
Increase in cash surrender value of life insurance policies 0 0
Decrease in restricted assets 0 0
Investments in subsidiaries 42,604 8,103
Proceeds from sale of fixed assets 0  
Capital expenditures 0 0
Repayments of notes receivable   (20,000)
Pay downs of investment securities 0 0
Investments in real estate, net 0 0
Net cash (used in) provided by investing activities 42,604 (11,897)
Cash flows from financing activities:    
Deferred financing costs 0  
Repayments of debt 0 20,000
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received (42,604) (8,103)
Intercompany dividends paid 195,005 174,152
Dividends and distributions on common stock 0 0
Distributions to non-controlling interest 0 0
Proceeds from issuance of Vector common stock 0  
Proceeds from exercise of Vector options 0  
Tax benefit of options exercised 0  
Other 0  
Net cash used in financing activities 152,401 186,049
Net (decrease) increase in cash, cash equivalents and restricted cash 0 0
Cash, cash equivalents and restricted cash, beginning of period 0 0
Cash, cash equivalents and restricted cash, end of period 0 0
Parent/Issuer | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities 122,305 118,890
Cash flows from investing activities:    
Sale of investment securities 16,186 10,940
Maturities of investment securities 45,798 16,899
Purchase of investment securities (76,094) (22,516)
Purchase of long-term investments 0  
Investments in real estate ventures 0 0
Purchase of subsidiaries 0 0
Distributions from investments in real estate ventures 0 0
Increase in cash surrender value of life insurance policies (311) (345)
Decrease in restricted assets (22) 14
Investments in subsidiaries (42,604) (8,103)
Proceeds from sale of fixed assets 0  
Capital expenditures 0 (15)
Repayments of notes receivable   20,000
Pay downs of investment securities 828 1,293
Investments in real estate, net 0 0
Net cash (used in) provided by investing activities (56,219) 18,167
Cash flows from financing activities:    
Deferred financing costs 0  
Repayments of debt (230,000) 0
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received 0 0
Intercompany dividends paid 0 0
Dividends and distributions on common stock (179,449) (169,571)
Distributions to non-controlling interest 0 0
Proceeds from issuance of Vector common stock 0  
Proceeds from exercise of Vector options 0  
Tax benefit of options exercised 0  
Other 0  
Net cash used in financing activities (409,449) (169,571)
Net (decrease) increase in cash, cash equivalents and restricted cash (343,363) (32,514)
Cash, cash equivalents and restricted cash, beginning of period 474,880 194,719
Cash, cash equivalents and restricted cash, end of period 131,517 162,205
Subsidiary Guarantors | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities 259,426 244,377
Cash flows from investing activities:    
Sale of investment securities 0 3,955
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Purchase of long-term investments 0  
Investments in real estate ventures 0 0
Purchase of subsidiaries 0 0
Distributions from investments in real estate ventures 0 0
Increase in cash surrender value of life insurance policies (462) (461)
Decrease in restricted assets 683 240
Investments in subsidiaries 0 0
Proceeds from sale of fixed assets 8  
Capital expenditures (3,425) (4,175)
Repayments of notes receivable   0
Pay downs of investment securities 0 0
Investments in real estate, net 0 0
Net cash (used in) provided by investing activities (3,196) (441)
Cash flows from financing activities:    
Deferred financing costs (36)  
Repayments of debt (720) (21,263)
Borrowings under revolver 204,506 261,058
Repayments on revolver (221,373) (264,654)
Capital contributions received 675 650
Intercompany dividends paid (153,868) (128,308)
Dividends and distributions on common stock 0 0
Distributions to non-controlling interest 0 0
Proceeds from issuance of Vector common stock 0  
Proceeds from exercise of Vector options 0  
Tax benefit of options exercised 0  
Other 0  
Net cash used in financing activities (170,816) (152,517)
Net (decrease) increase in cash, cash equivalents and restricted cash 85,414 91,419
Cash, cash equivalents and restricted cash, beginning of period 23,849 20,175
Cash, cash equivalents and restricted cash, end of period 109,263 111,594
Subsidiary Non-Guarantors | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities 8,623 20,693
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Purchase of long-term investments (1,000)  
Investments in real estate ventures (36,269) (6,132)
Purchase of subsidiaries (323) (370)
Distributions from investments in real estate ventures 30,934 37,819
Increase in cash surrender value of life insurance policies 0 0
Decrease in restricted assets 0 0
Investments in subsidiaries 0 0
Proceeds from sale of fixed assets 9  
Capital expenditures (6,733) (8,356)
Repayments of notes receivable   67
Pay downs of investment securities 0 0
Investments in real estate, net (1,910) (1,495)
Net cash (used in) provided by investing activities (15,292) 21,533
Cash flows from financing activities:    
Deferred financing costs 0  
Repayments of debt (154) (227)
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received 41,929 7,453
Intercompany dividends paid (41,137) (45,844)
Dividends and distributions on common stock 0 0
Distributions to non-controlling interest (285) (2,521)
Proceeds from issuance of Vector common stock 0  
Proceeds from exercise of Vector options 0  
Tax benefit of options exercised 0  
Other (46)  
Net cash used in financing activities 307 (41,139)
Net (decrease) increase in cash, cash equivalents and restricted cash (6,362) 1,087
Cash, cash equivalents and restricted cash, beginning of period 93,000 96,043
Cash, cash equivalents and restricted cash, end of period $ 86,638 $ 97,130